End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -99.00% | -99.00% |
Business Summary
Sales per Business
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Noah Berkowitz
CEO | Chief Executive Officer | 60 | 06-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Noah Berkowitz
CEO | Chief Executive Officer | 60 | 06-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 10,000,000 | 0 | 0 | 15.89 % |
Stock B | 1 | 2,586,326 | 2,000,000 ( 77.33 %) | 0 |
Company contact information
Synvista Therapeutics, Inc.
6 Campus Drive
07054, Parsippany
+
Sector
1st Jan change | Capi. | |
---|---|---|
-99.00% | 2 | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- SYNI Stock
- Company Synvista Therapeutics, Inc.